ICL Group Ltd. — Capital/Financing Update 2019

Dec 17, 2019

6-K 1 dp117728_6k.htm FORM 6-K

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of December, 2019

Field: Rule-Page

Field: /Rule-Page

Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.

(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.

Millennium Tower

23 Aranha Street

P.O. Box 20245

Tel Aviv, 61202 Israel

(972-3) 684-4400

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes No X

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes No X

Field: Page; Sequence: 1

Field: /Page

ISRAEL CHEMICALS LTD.

1. Notice of Potential Offering of Debentures in Israel

Field: Page; Sequence: 2

Field: /Page

Item 1

Israel Chemicals Ltd. (the “Company”) filed an interim report in Israel today to announce that it has commenced preparations for raising debt of about ILS 400 million by offering to the public, in Israel only, a new series of debentures. The Company intends to use the net proceeds from the potential offering for refinancing of existing debt and general corporate purposes. In preparation for the potential offering of debentures, the Company has published to the public in Israel a draft deed of trust.

The execution, timing, terms and amount of such contemplated offering have not been finally determined and are subject to further approval of the Company’s Board of Directors, and the approval of the Tel Aviv Stock Exchange. There is no assurance that the that the offering will take place.

The contemplated offering described in this report, if made, will be made in Israel to residents of Israel only. The debentures will not be registered under the U.S. Securities Act of 1933, as amended, and will not be offered or sold in the United States. This report shall not constitute the solicitation of an offer to buy any debentures.

Field: Page; Sequence: 3

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Kobi Altman
Name:	Kobi Altman
Title:	Chief Financial Officer

/s/ Aya Landman
Name:	Aya Landman
Title:	Global Corporate Secretary

Date: December 17, 2019

Field: Page; Sequence: 4; Options: Last

Field: /Page